Hanem LGE, et al
We recently identified the FOXO4 p53 axis as pivotal in maintaining the viability of senescent cells, and that senescent cells can be targeted selectively with the senolytic peptide FOXO4-DRI
Researchers combining retatrutide with recovery peptides should be especially attentive to nutritional adequacy and may benefit from stacking protocols that account for timing and injection scheduling
Choosing the right pharmacological treatment in these patients remains challenging due to the heterogeneous patient population, patients expectation of the treatment outcome, unavailability of efficacious drugs, and the multifactorial and incompletely understood underlying pathophysiology
And none of it happens overnight, which is exactly what makes it so easy to miss until the effects have already taken hold
Eaton S, Fukumoto K, Stefanutti G, Spitz L, Zammit VA, Pierro A: Myocardial carnitine palmitoyltransferase I as a target for oxidative modification in inflammation and sepsis